Cargando…
Evolving Role of Silodosin for the Treatment of Urological Disorders – A Narrative Review
Use of α-androgenic receptor blockers remains a mainstay therapeutic approach for the treatment of urological diseases. Silodosin is recommended over other α-blockers for the treatment of lower urinary tract symptoms (LUTS) and benign prostate hyperplasia (BPH), due to its high α(1A) uroselectivity....
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9427207/ https://www.ncbi.nlm.nih.gov/pubmed/36051157 http://dx.doi.org/10.2147/DDDT.S373659 |